SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-767345
Filing Date
2016-11-14
Accepted
2016-11-14 12:01:31
Documents
65
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d267416d10q.htm 10-Q 682837
2 EX-31.1 d267416dex311.htm EX-31.1 5981
3 EX-31.2 d267416dex312.htm EX-31.2 5990
4 EX-32.1 d267416dex321.htm EX-32.1 4215
  Complete submission text file 0001193125-16-767345.txt   3812724

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sndx-20160930.xml EX-101.INS 670511
6 XBRL TAXONOMY EXTENSION SCHEMA sndx-20160930.xsd EX-101.SCH 45426
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20160930_cal.xml EX-101.CAL 60219
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20160930_def.xml EX-101.DEF 167753
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20160930_lab.xml EX-101.LAB 349153
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20160930_pre.xml EX-101.PRE 258874
Mailing Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451
Business Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 161992490
SIC: 2834 Pharmaceutical Preparations